BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//OncoPlanning//Event//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:16199953-57d6-4cab-9d7d-71ea81df83cf@oncoplanning
DTSTAMP:20260524T194548Z
DTSTART:20260518T123000
DTEND:20260518T163000
SUMMARY:FDA Workshop: Contemporary Issues in Non-Muscle Invasive Bladder Cancer (NMIBC) Trial Design and Interpretation
DESCRIPTION:The FDA Oncology Center of Excellence is convening a workshop to explore critical issues in NMIBC trial design and interpretation.\n\nThis session will bring together perspectives from molecular biology\, clinical pathology\, urology\, and medical oncology to examine key scientific and clinical considerations.\n\nKey discussion topics:\n · Similarities and differences between papillary and carcinoma in situ histology in NMIBC—and their implications for demonstrating efficacy in clinical trials.\n· The current Bacillus Calmette-Guérin (BCG) shortage and its impact on clinical trial design.
LOCATION:FDA Great Room\, Bldg. 31\, Silver Spring\, United States
URL:https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/contemporary-issues-non-muscle-invasive-bladder-cancer-nmibc-trial-design-and-interpretation
END:VEVENT
END:VCALENDAR